Sei Investments CO Regenxbio Inc. Transaction History

Sei Investments CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$20.4 - $24.73 $407,551 - $494,055	19,978 New	19,978 $453,000
Q2 2019 Aug 14, 2019	SELL	$42.0 - $59.29 $341,166 - $481,612	-8,123 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$40.82 - $62.45 $331,580 - $507,281	8,123 New	8,123 $466,000
Q3 2018 Nov 08, 2018	SELL	$65.0 - $82.15 $814,255 - $1.03 Million	-12,527 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$27.2 - $74.35 $340,489 - $930,713	12,518 Added 139088.89%	12,527 $899,000
Q3 2017 Nov 06, 2017	BUY	$18.0 - $32.95 $162 - $296	9	9 $0

193

43.5M

58.9K

58.4K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $404M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.